Ipsen Pharmaceuticals Releases Half-Year Statement

Ipsen, a pharmaceutical company, has published its half-year statement for 2025. The statement includes key financial metrics.

Financial Metrics

• The company’s stock price has fluctuated within a 52-week range of 87.95 EUR to 125.6 EUR.
• The current close price is 102.5 EUR.
• Technical analysis reveals a price-to-earnings ratio of 23.95.
• The price-to-book ratio is 2.02.

Valuation Insights

The provided financial metrics offer insight into Ipsen’s valuation.